Abstract
Discoloration of the leg following vaccination is a relatively unknown entity. We carried out a study of discolored leg syndrome (DLS) during a 10-year consecutive period with the objective of characterizing DLS in infants following vaccination received in the Dutch National Vaccination Program as well as its occurrence and association with different vaccines. Discolored leg syndrome was defined as an even or patchy red, blue or purple discoloration of the leg(s) and/or leg petechiae with or without swelling. All reports of adverse events following immunization that were made to the passive surveillance system between 1994 and 2003 were included—a total of 1162 identified cases. Red, blue, purple discoloration and isolated petechiae were reported in 39, 19, 27 and 14% of these cases, respectively. Of these 1162 cases, 1105 were considered to be related to the vaccination, based on a predefined risk window with symptom onset after vaccination (48 h for discolorations and 2 weeks for petechiae). Of the 1105 cases, about 50% occurred after DTP-IPV+Hib1 vaccinations, and 30% occurred after DTP-IPV+Hib2 vaccinations. Discolored leg syndrome was frequently accompanied by fierce crying (78%). The median time interval between vaccination and the occurrence of DLS was 3.8 ± 46.7 h, and the median duration was short (2 ± 61.7 h). Advancing the vaccination schedule from 3 to 2 months of age caused a small increase in DLS. Discolored leg syndrome manifested mainly after the first and/or second vaccination. In addition to dose, the occurrence of DLS may be slightly age-dependent and self-limiting. The pathophysiology is unknown but may be the result of a vasomotor reaction. Future studies should elucidate the recurrence rate, identify risk factors and assess late outcomes.
Similar content being viewed by others
Abbreviations
- AEFI:
-
Adverse event following immunization
- aP:
-
Acellular pertussis vaccine
- DLS:
-
Discolored Leg Syndrome
- DTP-IPV:
-
Diphtheria–whole cell pertussis-tetanus-polio vaccine
- HepB:
-
Hepatitis B vaccine
- Hib:
-
Haemophilus influenzae type b vaccine
- MenC:
-
Meningococcen C vaccine
- MMR:
-
Measles–mumps–rubella vaccine
- RIVM:
-
National Institute for Public Health and the Environment
- RVP:
-
National Vaccination Program
References
Advisory Committee on Immunization Practices (ACIP) (2000) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 49:1–8
Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG (1994) The Vaccine Adverse Event Reporting System (VAERS). Vaccine 12:542–550
Chuh N, Lee N, Zawar V (2004) The diagnostic criteria of Gianotti–Crosti syndrome: are they applicable to children in India? Pediatr Dermatol 21:542–547
Corbett M, Abernethy DA (1999) Harlequin syndrome. J Neurol Neurosurg Psychiatry 66:544
Devillers AC, de Waard-van der Spek FB, Oranje AP (1999) Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Arch Dermatol 135:34–38
Ellenberg SS, Braun MM (2002) Monitoring the safety of vaccines: assessing the risks. Drug Saf 25:145–152
Gold MS, Noonan S, Osbourn M, Precepa S, Kempe AE (2003) Local reactions after the fourth dose of acellular pertussis vaccine in South Australia. Med J Aust 179:191–194
Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B (2003) Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. Vaccine 21:2298–2306
Hogun PA (2003) Gianotti–Crosti syndrome. In: Schachner L, Hansen RC (eds) Pediatric dermatology. Mosby, Edinburgh, pp 667–670
Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337:1512–1522
Lance JW, Drummond P, Gandevia SC, Morris JG (1988) Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatr 51:635–642
Pehr K, Moroz B (1993) Cutis marmorata telangiectatica congenita: long-term follow-up, review of the literature, and report of a case in conjunction with congenital hypothyroidism. Pediatr Dermatol 10:6–11
Rigante D (2006) Clinical overview of vasculitis syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 10:337–345
Vermeer-de Bondt PE, Labadie J, Rümke HC (1997) Adverse events following immunisation under the National Vaccination Programme of the Netherlands. Reports in 1994. National Institute for Public health and the Environment, Bilthoven, The Netherlands
Verschoor PL, Wilschut JT, de Jonge GA, Kostense PJ (1991) Frequent symptoms after DTPP vaccinations. Arch Dis Child 66:1408–1412
World Health Organization Collaborating Centre for International Drug Monitoring (1991) 14th Annual meeting of participating national centres. World Health Organization, Barcelona
World Health Organization (1991) Surveillance of adverse events following immunization: Field guide for managers of immunization programmes. World Health Organization, Geneva
Sources of support:
None
Author information
Authors and Affiliations
Corresponding author
Appendix—examples of two case reports
Appendix—examples of two case reports
Case 1
A 3-month-old male infant received his first DTP-IPV and Hib vaccination in both thighs. Four hours later he started to cry inconsolably. Both legs turned blue, with the discoloration ascending from the toes to the pelvic region. His face was ashen pale. He was administered paracetamol suppository and 30 min later the crying stopped. The color of the legs returned to normal. No fever and local reactions were noted. The second vaccinations were uneventful, but the third vaccinations were followed within a few minutes by crying, then by blue discoloration of his feet and red discoloration of his knees within 15 min.
Case 2
An 8-week-old female infant received her first DTP-IPV-Hib in the left leg. After 3.5 h, she woke up screaming. Both legs were discolored evenly fire-engine red, from the groin to the toe; the legs were swollen like “sausages”. After 1 h she calmed down and fell asleep. Four hours later the legs were still swollen and a patchy red. The injection site showed a little lump (<1 cm). The rectal temperature was 37.8°C. The following day she had unblanching spots on both legs with one superficial larger hematoma on one calf.
Rights and permissions
About this article
Cite this article
Kemmeren, J.M., Vermeer-de Bondt, P.E. & van der Maas, N.A.T. Discolored leg syndrome after vaccination—descriptive epidemiology. Eur J Pediatr 168, 43–50 (2009). https://doi.org/10.1007/s00431-008-0707-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-008-0707-0